December 15, 2025

Fixed-Duration Doublet Noninferior to Continuous Ibrutinib in CLL

Early findings from the CLL17 trial show that fixed-duration doublet regimens with venetoclax are noninferior to continuous ibrutinib therapy, with similar 3-year progression-free survival rates, for ...

The ASCO Post

December 15, 2025

ADA seeks representative for American Medical Association advisory committee

Nominations for the primary adviser position will be open from Jan. 15 to Feb. 15, 2026.

ADA News

December 15, 2025

How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development

Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.

The Medicine Maker

December 12, 2025

Roswell Park Offering CAR T Trial for Autoimmune Conditions

While most CAR T-cell therapies and clinical trials are directed at cancers, a new phase 1 trial at Roswell Park Comprehensive Cancer Center is open and recruiting patients with a variety of autoimmune conditions.

Roswell Park Comprehensive Cancer Center

December 12, 2025

Acupuncture May Improve Perceived Cognitive Difficulties in Breast Cancer Survivors

New findings from the phase II ENHANCE clinical trial indicate that both real and sham acupuncture improve breast cancer survivors’ perceived cognitive impairment more effectively than usual care alon...

The ASCO Post

December 12, 2025

Hormonal Changes Influence Uveitis Activity

Reproductive life stages linked to distinct uveitis activity patterns across the female lifespan

The Ophthalmologist

December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant

December 11, 2025

Myopia: A Public Health Emergency

Global experts declare childhood myopia a public health emergency in HOYA-led call to action

The Ophthalmologist

December 10, 2025

Optimizing Diagnostic Stewardship: The Lab Director’s Perspective

Programs that refine test ordering, performance, and reporting can reduce unnecessary treatments and enhance lab efficiency.

The Pathologist